Woodline Partners LP Viatris Inc Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Viatris Inc stock. As of the latest transaction made, Woodline Partners LP holds 893,414 shares of VTRS stock, worth $11.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

893,414

Previous 889,500 0.44%

Holding current value

$11.3 Million

Previous $9.46 Million 9.7%

% of portfolio

0.09%

Previous 0.09%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $40,392 - $47,476	3,914 Added 0.44%	893,414 $10.4 Million
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $15.8 Million - $19 Million	-1,403,596 Reduced 61.21%	889,500 $10.6 Million
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $12.3 Million - $15.2 Million	1,403,983 Added 157.91%	2,293,096 $24.8 Million
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $734,718 - $869,557	76,613 Added 9.43%	889,113 $8.77 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $7.33 Million - $8.36 Million	812,500 New	812,500 $8.11 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $17.4 Million - $23.1 Million	1,996,159 New	1,996,159 $22.2 Million
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $3.45 Million - $4.25 Million	-346,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $18 Million - $22.4 Million	-1,384,945 Reduced 79.99%	346,500 $4.95 Million
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $18.8 Million - $25.7 Million	1,385,217 Added 400.09%	1,731,445 $24.2 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $4.95 Million - $6.49 Million	346,228 New	346,228 $6.49 Million

Others Institutions Holding VTRS

# of Institutions

1,099

Shares Held

930M

Call Options Held

2.68M

Put Options Held

2.24M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.3B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Viatris Inc Transaction History